EMEA-002460-PIP01-18

Key facts

Active substance
Amantadine (hydrochloride)
Therapeutic area
Neurology
Decision number
P/0033/2019
PIP number
EMEA-002460-PIP01-18
Pharmaceutical form(s)
Prolonged-release capsule, hard
Condition(s) / indication(s)
Treatment of Parkinson's disease and parkinsonism
Route(s) of administration
Oral use
Contact for public enquiries
Adamas Pharmaceuticals LLC

Tel.  +1 5104503500
E-mail: https://www.adamaspharma.com/contact-us/

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating